Systematic Reviews
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Oct 15, 2020; 11(10): 459-467
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.459
Impact of technology use in type 2 diabetes distress: A systematic review
Patricia Vieira, Renata Kobayasi, Filomena Pereira, Isabella Martins Zaia, Sandra Umeda Sasaki
Patricia Vieira, Department of Health, Iron Saúde, Alcabideche 2649-517, Portugal
Renata Kobayasi, Department of Internal Medicine, University of Sao Paulo, Sao Paulo 05410-020, Brazil
Filomena Pereira, School of Psychology and Science of Education, University of Porto, Porto 4200-465, Portugal
Isabella Martins Zaia, Sandra Umeda Sasaki, Medical School UNICID, Sao Paulo 03071-000, Brazil
Author contributions: Sasaki S and Vieira P designed the study, performed the research and analyzed the data; Pereira F, Zaia I and Kobayasi R reviewed the paper; All authors read and approved the final manuscript.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
PRISMA 2009 Checklist statement: The guidelines of the PRISMA 2009 statement have been adopted.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Sandra Umeda Sasaki, MD, PhD, Medical Assistant, Professor, Research Scientist, Surgeon, Medical School UNICID, Cesario Galero 488 Street Tauapé, Sao Paulo 03071-000, Brazil.
Received: April 24, 2020
Peer-review started: April 24, 2020
First decision: June 15, 2020
Revised: July 8, 2020
Accepted: August 31, 2020
Article in press: August 31, 2020
Published online: October 15, 2020
Research background

High diabetes distress is associated with poorer diabetes outcomes. Technological interventions have been used as modern tools of communication to improve communication and can impact diabetes self-management, engagement and adherence. Understanding the impact of programs with technological interventions regarding disease management on type 2 diabetes distress bears clinical significance.

Research motivation

Review authors disagree about the benefits of this technology in type 2 diabetes distress. We systematically reviewed randomized controlled trials that studied the impact of technology interventions on type 2 diabetes distress.

Research objectives

The goal of this study is to provide comprehensive overview of the impact of technology interventions on type 2 diabetes distress.

Research methods

We systematically searched MEDLINE, PubMed and EBSCO with the Boolean logic search terms were: (1) T2Diabetes; (2) Diabetes distress and (3) Technology OR mobile OR phone OR application OR web. We also systematically searched the reference lists of the included studies and relevant reviews.

Research results

We found nine full articles that met the inclusion criteria. Six out of nine articles showed that technology interventions had a positive impact on diabetes distress scale scores when compared with the initial data. Among these six articles, five showed a greater reduction in the diabetes distress scores from control interventions. Web-based interventions had good results when users received personalized feedback and routine caregiver support and attention.

Research conclusions

Technology-based interventions have a positive impact on type 2 diabetes distress management, and programs that include routine caregiver support and attention show the best results.

Research perspectives

These review findings could contribute to the development of new approaches on the elaboration of technological strategies to cope with type 2 diabetes distress and consequently improve treatment outcomes, resulting in patient well-being and better biological consequences in the management of type 2 diabetes.